In recent years, the management of esophageal and esophagogastric junction cancers has undergone a profound transformation, driven by the introduction of novel perioperative strategies, the integration of systemic therapies with advanced locoregional ap-proaches, and the rapid development of precision medicine.
Against this rapidly evolving landscape, the event aims to provide an up-to-date overview of the key topics that are reshaping clini-cal practice. Through a critical review of the latest scientific evidence, the program will explore perioperative treatment strategies, the role of immunotherapy and targeted therapies, innovative radiotherapy techniques, the potential role of total neoadjuvant ther-apy, and organ-preservation approaches.
Through the contributions of leading national and international experts and a multidisciplinary exchange among the healthcare pro-fessionals involved in the management of these patients, the meeting aims to promote the dissemination of the most up-to-date knowledge, foster interdisciplinary collaboration, and support the adoption of increasingly appropriate, personalized, and evidence-based diagnostic and therapeutic strategies.